Hiroki Yano
Yatomi, 4988502, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Delayed elimination of methotrexate associated with use of DPP-4 inhibitors during high-dose methotrexate therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: February 01, 2026
Refining the simplified frailty scale to improve the risk stratification of patients with multiple myeloma.
Journal: Journal of geriatric oncology
Published: November 01, 2025
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Journal: Cancer science
Published: December 14, 2022
Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study.
Journal: Japanese journal of clinical oncology
Published: August 26, 2021
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Journal: Haematologica
Published: October 15, 2020
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.
Journal: International journal of hematology
Published: October 30, 2018
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902).
Journal: Annals of hematology
Published: November 20, 2015
A case of multiple myeloma in a young adult, discovered on the basis of an abnormal finding on a chest X-ray film
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 02, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026